| - Industry | - Sector | - CEO | TWSE Exchange | - ISIN |
| Taiwan Country | 104 Employees | - Last Dividend | - Last Split | - IPO Date |
Heron Neutron Medical Corp. is a pioneering healthcare technology company established in 2016 and based in Zhubei, Taiwan. The company specializes in the development, manufacture, and integration of advanced medical equipment, primarily focusing on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These innovative solutions are meticulously designed to provide precise and effective treatments for cancer by employing advanced technologies in neutron source targets, accelerators, beam shaping, treatment control, and planning. A notable aspect of Heron Neutron Medical Corp. is its comprehensive approach as a solution provider; not only does the company develop cutting-edge AB-BNCT devices, but it also integrates boron-containing therapeutic agents. This allows Heron Neutron Medical Corp. to deliver coordinated device-and-drug solutions tailored specifically for hospitals and research institutions, ultimately enhancing clinical efficiency, enabling more precise tumor targeting, reducing side effects when compared to conventional methods, and streamlining the overall patient care experience.
Heron Neutron Medical Corp. specializes in advanced AB-BNCT systems that utilize neutron beams to target and treat cancer cells effectively. The technology leverages the unique properties of boron-10 isotopes, which, when exposed to thermal neutrons, produce high-energy alpha particles that selectively destroy tumor cells while sparing surrounding healthy tissues.
The company integrates boron-containing agents into its treatment protocols, creating synergistic effects with its AB-BNCT systems. These agents enhance the uptake of boron in tumor cells, thereby improving the efficacy of neutron capture therapy and facilitating better treatment outcomes.
Heron Neutron Medical Corp. employs state-of-the-art beam shaping technologies to focus neutron beams precisely on tumors, minimizing the exposure of healthy tissues to radiation. This innovation aids in achieving optimal dose distribution and maximizes therapeutic impact.
To ensure accuracy and efficacy, the company offers advanced treatment control and planning systems. These systems aid clinicians in strategizing and personalizing treatment plans based on the specific characteristics of each patient’s cancer, thus enhancing the overall treatment experience.
Heron Neutron Medical Corp. emphasizes collaboration with healthcare providers and research institutions. The company offers training, ongoing support, and consultation services to ensure the successful implementation and utilization of their AB-BNCT systems and related therapies.